Right to Try for Individualized Treatments Act

This bill amends the federal Right to Try law to let patients with a life-threatening disease or condition, or a severely debilitating illness, request investigational individualized medical treatments. These are drugs or biological products designed for one patient based on that patient's genetic profile. To qualify, a physician must certify that the patient considered approved treatment options, and the patient must give written informed consent, including an additional consent form signed by the physician and a witness. Manufacturers working within a health care facility that follows federal human-subject protection rules may offer these treatments but are not required to.

Full text and official record on Congress.gov

Sponsors

• Ron Johnson Republican sponsor
• 1 cosponsors